Trials / Terminated
TerminatedNCT00242827
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Cephalon · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
Detailed description
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral CEP-701 |
Timeline
- Start date
- 2006-04-01
- Completion
- 2007-05-01
- First posted
- 2005-10-21
- Last updated
- 2012-08-23
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00242827. Inclusion in this directory is not an endorsement.